chrisvoncsefalvay/vaers-outcomes huggingface dataset:
was bladder incontinent; had such and an extreme reaction; lost all their muscle strength; could not move; slid off the bed and was sitting on the floor; This spontaneous case was reported by a patient and describes the occurrence of URINARY INCONTINENCE (was bladder incontinent), IMMUNISATION REACTION (had such and an extreme reaction), MUSCULAR WEAKNESS (lost all their muscle strength), MOBILITY DECREASED (could not move) and FALL (slid off the bed and was sitting on the floor) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 013M20A) for COVID-19 prophylaxis.     The patient's past medical history included Leukemia (has had leukemia before and that it was more important to get the vaccine). Concurrent medical conditions included Diabetes.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URINARY INCONTINENCE (was bladder incontinent), IMMUNISATION REACTION (had such and an extreme reaction), MUSCULAR WEAKNESS (lost all their muscle strength), MOBILITY DECREASED (could not move) and FALL (slid off the bed and was sitting on the floor). At the time of the report, URINARY INCONTINENCE (was bladder incontinent), IMMUNISATION REACTION (had such and an extreme reaction), MUSCULAR WEAKNESS (lost all their muscle strength), MOBILITY DECREASED (could not move) and FALL (slid off the bed and was sitting on the floor) outcome was unknown.            Concomitant products included diabetes medication.  After the  second dose patient had such and an extreme reaction and went to the hospital in an ambulance. Patient lost all their muscle strength, slid off the bed and was sitting on the floor, could nott move and had bladder incontinent.  Patient said that 4 hours later, was sent home from the hospital after receiving IV fluids.   This case was linked to MOD-2022-666108 (Patient Link).
FEVER, ACHES, SORE THROAT, SWOLLEN GLANDS, HEADACHE, STIFF NECK...SO FAR GOING ON TWO DAYS
After 30 minutes observation for history of anaphylaxis to codeine, pt left ambulatory and asymptomatic. Returned  complaining of face, throat, and bilateral extremity swelling and difficulty breathing. EpiPen was administered . Signs and symptoms began to resolve immediately. Pt agreed to go directly to urgent care
This spontaneous report was received from a pharmacist referring to a 65 year old male patient. The patient's concurrent conditions included erythromycin allergy and possibly clindamycin allergy. The patient's concomitant medications included an unspecified blood pressure medicine and an unspecified cholesterol medicine. On 09-FEB-2018, the patient was vaccinated with PNEUMOVAX 23 lot # N025656 with expiration date 19-APR-2019, intramuscularly, for prophylaxis (dose was not provided). It was stated that after receiving PNEUMOVAX 23, the patient noticed floater in his eye which went away later on the same date. On 11-FEB-2018, the patient experienced "red streak on arm but not where shot was". The patient recovered from the event on an unspecified date in February 2018. On an unspecified date in February 2018, the patient "was seeing water dripping from ceiling of truck which was not actually there". No treatment was given for the events. At the time of reporting, the outcome of hallucination, visual was reported as not recovered. The causality assessment between the events with PNEUMOVAX 23 was not provided.
5 seizures which continued, even while on Keppra, until a higher dose was given.
This spontaneous report as received from a registered nurse concerning a child who on 14-AUG-2012, was vaccinated with a dose of M-M-R II (lot# 1251AA, exp 01-AUG-2013). The nurse stated that the child might have been vaccinated with improperly stored M-M-R II. M-M-R II was exposed to 68 F for 9 hours and then on Wednesday last week "on 15-AUG-2012", the temperature went to 48F for 1 hour. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
arm of injection hot to touch; arm swollen at the injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm of injection hot to touch) and VACCINATION SITE SWELLING (arm swollen at the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced VACCINATION SITE WARMTH (arm of injection hot to touch) and VACCINATION SITE SWELLING (arm swollen at the injection site). At the time of the report, VACCINATION SITE WARMTH (arm of injection hot to touch) and VACCINATION SITE SWELLING (arm swollen at the injection site) had not resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Reporter did not allow further contact
Immediate sore shot site, 10 days later mild fatigue, joint soreness, dizziness affecting balance, achy eyes ,trouble  focusing when reading.
Asymptomatic; SARS-CoV-2 PCR+ on 2/21/2022.
Patient was given the 6m-4y Pfizer dose, instead of 5y-11y.  She was also not due for a booster yet--3rd dose was administered too early.  No adverse effects noted.
Patient was inadvertently administered Tdap instead of flu vaccine.  Patient reported during infancy she had allergic reaction to pertussis but cannot recall reaction and was told she would likely grow out of it.
suicidal thoughts; Depression; Chest pain; Fingers go numb/my arm feels numb; lack of sleep and sleeping issues; Nightmares; Stressed out; Weakness; Runny Nose; very angry; Headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of SUICIDAL IDEATION (suicidal thoughts) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2019.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SUICIDAL IDEATION (suicidal thoughts) (seriousness criterion medically significant), DEPRESSION (Depression), CHEST PAIN (Chest pain), HYPOAESTHESIA (Fingers go numb/my arm feels numb), SLEEP DISORDER (lack of sleep and sleeping issues), NIGHTMARE (Nightmares), STRESS (Stressed out), ASTHENIA (Weakness), RHINORRHOEA (Runny Nose), ANGER (very angry) and HEADACHE (Headache). At the time of the report, SUICIDAL IDEATION (suicidal thoughts) and ANGER (very angry) outcome was unknown and DEPRESSION (Depression), CHEST PAIN (Chest pain), HYPOAESTHESIA (Fingers go numb/my arm feels numb), SLEEP DISORDER (lack of sleep and sleeping issues), NIGHTMARE (Nightmares), STRESS (Stressed out), ASTHENIA (Weakness), RHINORRHOEA (Runny Nose) and HEADACHE (Headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2019, COVID-19: positve Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications was not provided.  Company comment: Very limited information regarding the events has been provided at this time.  Further information is not expected.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Initial Additional information received On 04-May-2021: Initial Additional information received. On 10-May-2021: Initial Additional information received. On 17-May-2021: Initial Additional information received. On 20-May-2021: Initial Additional information received.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information is not expected.
Rash began day of vaccine at site of VZV, Lasted 3 days before seeking care. Exam: urticarial rash 1 cm to site. Extending laterally with diameter 15 cm with induration and tenderness.
On the second day after the shot, I experienced shortness of breath. This symptom occurred off and on throughout the days and nights in the following 2 weeks. I saw my personal physician a few days after these syptoms began. He ordered a chest x ray which showed no adverse events. The shortness of breath sypmtoms gradually went away each day. As of today (July 20, 2021), the sympotms are almost non existent.
This case was reported by a physician via call center representative and described the occurrence of rigors in a 62-year-old male patient who received Shingrix (batch number YS53Y, expiry date 30th January 2020) for prophylaxis. Concomitant products included Venlafaxine, Aspirin, Wellbutrin Xl, Atorvastatin, Brilinta, Metoprolol Succin and Omega Fatty Acid. On 9th February 2018, the patient received the 1st dose of Shingrix .5 ml. On an unknown date, less than a year after receiving Shingrix, the patient experienced rigors. On an unknown date, the outcome of the rigors was recovered/resolved. The reporter considered the rigors to be related to Shingrix. Additional details were provided as follows: The patient was administered Shingrix in the left arm. The patient experienced severe rigors with first dose of Shingrix. The reaction lasted for about 12 hours approximately. This case was linked to the case US2018GSK072776, reported by the same reporter for the same patient who experienced same event after the 2nd dose. Follow up was received by a physician on 1st June 2018: The reporter's contact details were updated. The patient's demographic details were updated. The VAERS details were updated. Sender's Comments: US2018GSK069429: Previous VAERS submission in paper format.
Patient filed a claim for injury to shoulder due to the vaccine that was given. Patient claims that she was barely able to lift her arm up (due to it being so sore) and says it was due to the shot being given too high. She said she has required physical therapy and steroid shots to compensate for the pain and immobility.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 24-DEC-2015 at 11:25, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high and low temperatures were 6.3 and 5.3 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Swelling and soreness of lymph nodes in left armpit; Swelling and soreness of lymph nodes in left armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05May2021 at 14:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. On 06May2021 at 12:00, the patient experienced swelling in left armpit and soreness of lymph nodes in left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling in left armpit and soreness of lymph nodes in left armpit was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
kicking my ass; This case was reported by a consumer via interactive digital media and described the occurrence of feeling abnormal in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling abnormal. On an unknown date, the outcome of the feeling abnormal was unknown.   The reporter considered the feeling abnormal to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-APR-2022  Reporter's Comments: This case was received from the consumer via interactive digital media. The patient reported that Shingle vaccine was kicking his/her ass. Additional Supportive Information: The follow-up would not possible as no contact details were available.
pain travelled to jaw; injection site pain; A spontaneous report was received from a consumer concerning herself, who was an 80-year-old, female patient who received Moderna's COVID-19 vaccine and experienced pain in the place she got the shot and it traveled up to her jaw.  The patient's medical history was not provided. Concomitant products known to have been used by the patient included Clonazepam, Furosemide, Gabapentin, Tramadol And HFA inhaler.  On 04 Jan 2021 at approximately 17:52, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 0251J20A) for prophylaxis of COVID-19 infection.    On 04 Jan 2021 at approximately 22:00, about 4 hours after she received the mRNA-1273 vaccination, the patient experienced Pain in the place she got the shot and it traveled up to her jaw. Patient stated that the shot itself was very simple. Treatment information as stated by the patient included Tramadol and used Marijuana but that did not help the pain.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The outcome of the event, pain in the place she got the shot and it traveling up to her jaw, was considered unknown.  The reporter did not provide causality for the events.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
Information has been received from a licensed practical nurse concerning a 9 year old female with no pertinent medical history or drug reactions/allergies, who on 05 Sept 2006 and 03 Nov 2006 was vaccinated with the first and second doses of Gardasil (lot 653735/0688F). There was no concomitant medication. Subsequently the patient experienced thinning of hair or alopecia. Unspecified medical attention was sought. At the time of this report the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/5/2007.  Initial and follow-up information has been received from a licensed practical nurse concerning a 9 year old female with no pertinent medical history or drug reaction/allergies, who on 10-OCT-2006 was vaccinated intramuscularly with the first dose of GARDASIL (0.5 ml) (lot # 653735/0688F).  There was no concomitant medication.  Subsequently, approximately ten days after vaccination on approximately 20-OCT-2006, the patient's mother noticed a balding spot behind the patient's ear.  The patient used a steroid cream on the area and had an appointment with a dermatologist.  It was reported that the patient has some hair re-growth but not in the whole area.  The patient's mother was unsure about the completion of the recommended vaccine schedule.  No further information is expected.
About 6 hours after flu administered; pt c/o rash over chest & upper back, both arms. Began to itch after questioned about itch. Rash gone in 24 hours.
After she received her COVID booster she had a sensation of being flushed with elevation of her blood pressure and pulse; she started taking some Benicar at request of physician with some improvement of her symptoms and blood pressure
1st dose on 2019, now wants to get 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 2019, batch number:AP257, expiry date: 26th November 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist reported that patient received 1st dose of Shingrix and now wanted to complete schedule. The reporter asked how to proceed. Till the time of reporting the patient did not received 2nd dose, which led to incomplete course of vaccination. The reporter did not consent to follow-up.  The case has been linked with the case US2022046171 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022046171:Same Reporter
Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, ARTHRALGIA (Joint pain) outcome was unknown. Not Provided. No concomitant medications were reported.No treatment medications were reported.
Fever, chills, and pulmonary infiltrates on chest Xray.  This worsened over time and resulted in an inpatient admission on 10/13/2011 Hospital.  She had developed high oxygen needs and required a bronchoscopy.  She did not have any infection on bronchoscopy.  She then require high dose steroids to improve her hypoxemia.  This reaction is most consistent with an organizing pneumonia (non-infectious) pattern on the chest CT and clinically.  Please contact me regarding this case if there are questions.
Appox. 16 hours after injection I started shivering and cold sweats. was weak. and just out of it. Went to bed and by mid afternoon shivers were gone as well as sweating. Slept all day and into the evening, by 10pm or so all seemed back to normal. Mid afternoon I sat up on the edge of the bed to go to the bathroom and passed out falling on my left knee (bad one) and hit my forehead on the bathroom door scraping and bruising same above left eye brow. Walking with pain in left knee but getting better daily.
Started getting a temperature at 6pm, then began serious shaking by 8pm; started with ice packs.  Temperature peaked at 102.1 around 11pm.  Terrible headache, and constant urinating.  Put ice bags / cold compresses on my head, armpits, groin and chest.  Temperature dropped to below 100 degrees by 2:45am.  Next day, slightly elevated temperature between 99 and 100 degrees all day, still headaches. No appetite.    Today, still headaches, no appetite but temperature is in the 98 to 99 degree range so far.  I am concerned because this was the most severe reaction I have ever experienced with the flu vaccine.  (My wife, had absolutely no reaction).  Hoping to find out if  perhaps there is another senior vaccine that is safer for Leukemia patients.      Thanks
Child experienced urinary and bowel incontinence with loose stools one day following MMR, varicella and flu vaccines. Sent home from school. Child also experiences sore throat, aches, fatigue, fluctuating low grade fever, cough, red cheeks for 3-4 weeks. Child was simply not well from 11/9/16 through 4/23/17, with numerous flu-like symptoms and an inability to overcome them. Child woke on 4/23/17 with urinary incontinence. Complained of extreme fatigue after waking. Went right back to bed, slept for two hours and awoke screaming in excruciating pain. Stated his knees hurt, legs were weak, back of his neck hurt and had a hard time sitting up independently from a lying position. Child could not bear weight on legs. Would not let anyone touch them. Fever 101.8 after 6 mL ibuprofen. Visibly huge swollen lymph nodes in sides of neck, red cheeks, legs and knees extremely hot to touch. Child taken to ER, diagnosed with virus (unspecified) and given ibuprofen. Child able to wobble few steps with help of dr and mom. Child returned home. Child did not urinate for 14 hours, despite drinking fluids. Returned to ER on 4/24/17. Child had fever despite ibuprofen, swollen lymph nodes in neck, severe knee pain, unable to bear weight or walk, neck pain subsided by second day. Child also had dark urine, sensory hallucinations on tongue  felt like there was a hair on tongue, although we checked numerous times and it did not exist, performed constant odd repetitive hand-to-mouth movements stating he could not stop sticking fist in mouth, lethargic, dark eyes, spaced-out. Child placed on IV fluids and anti-inflammatory meds overnight. Child fever broke 4/15/17 and was able to walk. Child was discharged home but has not been the same since episode. Steady runny nose, extreme impulsivity, extreme defiance (never experienced before), irritability, occasional daytime loss of bladder and bowel, aggression and lingering cough to date. Just not back to normal self. On 5/22/17, along with older sister who was vaccinated at same time/day/place and is experiencing bizarre symptoms (separate report), child diagnosed with PANDAS/PANS due to vaccine injury triggering autoimmune response that is attacking the brain.